Indee Labs
Enabling T cell immunotherapy discovery, development and manufacturing
Ryan Pawell · 1 founder
Profile coverage4 of 8 · missing Funding, Signals, Customers, Stack / tools · last run 8/11/2026
About
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.